PLSE: Pulse Biosciences Company Sales Revenue

Pulse Biosciences, Inc. (PLSE) is implementing breakthrough non-thermal ablation, which is currently in the initial market penetration stage. The company's annual sales volume demonstrates returns from operational processes, while 0.00 shows the current value of the metric. Diversification into oncology and cardiology mitigates risks, although geopolitical tensions and sanctions hinder the export of complex systems to certain regions.

Revenue and Sales Volume: Pulse Biosciences (PLSE) for 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Pulse Medical (PLSE)

- stock value and consensus price forecast:

Stock Quotes Pulse Biosciences|PLSE - Consensus Target

- market capitalization information:

Market Value Pulse Corp|PLSE - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Pulse Biosciences|PLSE - Book Capitalization|Market-to-Book Ratio pulsebiosciences.com|PLSE - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

PLSE - Net Income|Expected Net Income Pulse Biosciences, Inc.|PLSE - P/E Multiple|Projected Price to Earnings Ratio Pulse Biosciences Inc|PLSE - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Pulse Medical|PLSE - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Pulse Biosciences|PLSE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months pulsebiosciences.com|PLSE - Earnings per share growth in current year|Net earnings per share change forecast for next year Pulse Biosciences, Inc.

- company sales and revenue statistics:

PLSE - Company Revenue|Company Future Sales Volume Pulse Biosciences, Inc.|PLSE - P/S Multiple|Market Cap to Future Revenue Ratio Pulse Corp|PLSE - Sales Growth YoY (Last Twelve Months)

Summary company analysis:PLSE Pulse Biosciences, Inc.

Pulse Biosciences, Inc. (PLSE) generates revenue through the sale of high-tech equipment for nanosecond pulsed therapy in dermatology and aesthetics. This sales performance for Pulse Biosciences, Inc. (PLSE) reflects the daily volume of products sold, measuring the scaling pace of the operating business. The metric is calculated as the sum of all confirmed transactions per trading day. Steady growth confirms an expanding market share, although sharp spikes may signal overheating demand and a risk of declining margins.

Key competitors